the problem of hypergastrinemia in patients with the syndrome of multiple endocrine neoplasia ( men type 1 ) has become increasingly controversial since the introduction of the antisecretory h2 antagonists for the treatment of the zollinger-ellison syndrome ( zes ) .
C0027662
syndrome
C0025267
men type 1